Followers

Monday, October 17, 2011

Teva sells generic rights to Cephalon drugs to Par

Teva sells generic rights to Cephalon drugs to Par The Teva-Cephalon deal remains under review by the US Federal Trade Commission and the European Commission. Teva Pharmaceuticals has sold the rights to three products to avoid a conflict related to its recent acquisition of Cephalon. ... Teva sells generic rights to Cephalon drugs to Par

No comments:

Post a Comment

Popular Posts